O'Shaughnessy Asset Management, LLC Pro Phase Labs, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$4.23 - $7.53 $163,857 - $291,689	-38,737 Reduced 66.15%	19,822 $86,000
Q2 2023 Aug 11, 2023	BUY	$7.15 - $9.78 $32,654 - $44,665	4,567 Added 8.46%	58,559 $425,000
Q1 2023 May 12, 2023	SELL	$6.62 - $9.57 $5,938 - $8,584	-897 Reduced 1.63%	53,992 $411,000
Q4 2022 Feb 10, 2023	BUY	$8.78 - $12.47 $123,236 - $175,028	14,036 Added 34.36%	54,889 $528,000
Q3 2022 Nov 14, 2022	BUY	$8.96 - $14.7 $366,042 - $600,539	40,853 New	40,853 $461,000

1.71M

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $10.1M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.